Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
SKRR to Commence Uranium Drill Program to Test Conductors at Clearwater West (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum ProMIS Neurosciences Inc PMN

Healthcare Biotechnology
ProMIS Neurosciences Inc. is a development stage biotechnology company. The Company is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA), an alpha-synucleinopathy. Its proprietary target discovery engine... see more

NDAQ:PMN - Post Discussion

ProMIS Neurosciences Inc > predictions for tomorrow?
View:
Post by Gbathat on Jun 29, 2021 11:35pm

predictions for tomorrow?

a. we hope to make a deal someday
b. we made a deal
c. we re-elected people that cannot make a deal, no other updates
d. we have new management, board stepping down (TB's preference)
e. _________
Comment by BottomBroker on Jun 30, 2021 8:53am
 a and c, sadly.  I hope I'm wrong. 
Comment by G1945V on Jun 30, 2021 9:13am
BottomBrocker...If you know, are we able to access the AGM online? G1945V
Comment by BottomBroker on Jun 30, 2021 9:47am
Not that I'm aware of. RC would likely know. 
Comment by DavidKingCanada on Jun 30, 2021 1:27pm
Hoping for a Press Release first week of July with any news regarding Revenue! SP has stabilized around the low 20s for now. 
Comment by Gbathat on Jun 30, 2021 7:04pm
And the answer is e. _______________ nada. Hopefully we hear something tomorrow, at least a recap of the meeting and outlook. Aducanumab was approved on June 7th... my days have been flying by, but it is starting to feel like a while ago. 
ProMIS Neurosciences Inc
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities